| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.61 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.32 | 3e-08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.32 | 8e-08 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.31 | 1e-07 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.26 | 0.03 |